BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 78524)

  • 1. Suppression of chronic allergic encephalomyelitis: relevance to multiple sclerosis.
    Raine CS; Traugott U; Stone SH
    Science; 1978 Aug; 201(4354):445-8. PubMed ID: 78524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic relapsing experimental allergic encephalomyelitis. Correlation of circulating lymphocyte fluctuations with disease activity in suppressed and unsuppressed animals.
    Traugott U; Stone SH; Raine CS
    J Neurol Sci; 1979 Mar; 41(1):17-29. PubMed ID: 86602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and suppression of experimental allergic encephalomyelitis in the non-human primate.
    Rauch HC; Einstein ER
    J Neurol Sci; 1974 Sep; 23(1):99-116. PubMed ID: 4136815
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis.
    Raine CS; Traugott U
    Ann N Y Acad Sci; 1984; 436():33-51. PubMed ID: 6085228
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic relapsing experimental autoimmune encephalomyelitis. treatment with combinations of myelin components promotes clinical and structural recovery.
    Traugott U; Stone SH; Raine CS
    J Neurol Sci; 1982 Oct; 56(1):65-73. PubMed ID: 6183403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental allergic encephalomyelitis in guinea pigs. Influence of thymosin fraction V on the disease.
    Woyciechowska J; Goldstein AL; Driscoll B
    J Neuroimmunol; 1985 Jan; 7(4):215-9. PubMed ID: 2578135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of encephalitogen in incomplete Freund's adjuvant in the induction of experimental allergic encephalomyelitis in Hartley guinea pigs.
    Lebar R; Vincent C
    J Neuroimmunol; 1984 Jun; 6(3):187-96. PubMed ID: 6202714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lewis Rat Model of Experimental Autoimmune Encephalomyelitis.
    Pitarokoili K; Ambrosius B; Gold R
    Curr Protoc Neurosci; 2017 Oct; 81():9.61.1-9.61.20. PubMed ID: 29058769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid.
    Eidinoff H
    Med Hypotheses; 1988 Apr; 25(4):219-22. PubMed ID: 2452965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic relapsing experimental autoimmune encephalomyelitis. Ultrastructure of the central nervous system of animals treated with combinations of myelin components.
    Raine CS; Traugott U
    Lab Invest; 1983 Mar; 48(3):275-84. PubMed ID: 6186840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHRONIC DISSEMINATED ALLERGIC ENCEPHALOMYELITIS IN GUINEA PIGS.
    STONE SH; LERNER EM
    Ann N Y Acad Sci; 1965 Mar; 122():227-41. PubMed ID: 14313480
    [No Abstract]   [Full Text] [Related]  

  • 13. The lysosomal enzymic activities of lymphocytes in experimental allergic encephalomyelitis.
    Clausen J; Jorgensen P
    Int Arch Allergy Appl Immunol; 1972; 43(3):457-68. PubMed ID: 4117489
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigs.
    Keith AB; Arnon R; Teitelbaum D; Caspary EA; Wisniewski HM
    J Neurol Sci; 1979 Jul; 42(2):267-74. PubMed ID: 90129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro response to basic protein in experimental allergic encephalomyelitis: effect of pretreatment with basic protein in incomplete adjuvant.
    Lisak RP; Zweiman B; Dzida L; Rosenblum F; Rorke LB; Barger G
    Cell Immunol; 1980 Jul; 52(2):443-50. PubMed ID: 6159988
    [No Abstract]   [Full Text] [Related]  

  • 16. The presence of specific antigen-reactive cells during the induction, recovery, and resistance phases of experimental allergic encephalomyelitis.
    Waxman FJ; Fritz RB; Hinrichs DJ
    Cell Immunol; 1980 Jan; 49(1):34-42. PubMed ID: 6153156
    [No Abstract]   [Full Text] [Related]  

  • 17. Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis.
    Steinman L
    J Exp Med; 2001 Sep; 194(5):F27-30. PubMed ID: 11535639
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of chronic-relapsing experimental allergic encephalomyelitis in strain-13 guinea pigs by administration of liposome-associated myelin basic protein.
    Strejan GH; Gilbert JJ; St Louis J
    J Neuroimmunol; 1984 Nov; 7(1):27-41. PubMed ID: 6209299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental allergic encephalomyelitis in the guinea pig: variation in peripheral blood lymphocyte responsiveness to myelin basic protein during disease development.
    Lyman WD; Kadish AS; Raine CS
    Cell Immunol; 1981 Sep; 63(2):409-16. PubMed ID: 6168397
    [No Abstract]   [Full Text] [Related]  

  • 20. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.